Flightless I Homolog Reverses Neo-Endocrine Therapy Resistance through YBX1/PD-L1 Axis Mediated-Immune Evasion in Prostate Cancer
Hailong Ruan(Union Hospital), Ke Chen(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 1
Related Papers
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study
|American Journal of Epidemiology|2018|73
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
|Oncotarget|2014|66
Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition
|International Journal of Oncology|2017|46